| Name | 5-Ethynyluridine |
| Description | 5-Ethynyluridine can be used to label newly synthesized RNA. This approach, named capture of the newly transcribed RNA interactome using click chemistry (RICK), systematically captures proteins bound to a wide range of RNAs, including nascent RNAs and traditionally neglected nonpolyadenylated RNAs. |
| In vivo | EU labelling can be used to examine transcription in vivo in mouse models of nervous system disorders. Injection of EU directly into the cerebellum results in reproducible labelling of newly transcribed RNA in cerebellar neurons and glia, with cell type-specific differences in relative labelling intensities, such as Purkinje cells exhibiting the highest levels. EU-labelling accumulating into cytoplasmic inclusions, indicating that EU, like other modified uridines, may introduce non-physiological properties in labelled RNAs[1]. |
| Storage | Shipping with blue ice/Shipping at ambient temperature. |
| Solubility Information | 10% DMSO+40% PEG300+5% Tween-80+45% Saline : 1 mg/mL (3.73 mM), Sonication is recommended.
DMF : 10 mg/mL (37.28 mM), Sonication is recommended.
PBS (pH 7.2) : 5 mg/mL (18.64 mM), Sonication is recommended.
DMSO : 55 mg/mL (205.06 mM), Sonication is recommended.
|
| Keywords | RNA transcripts | purkinje cells | NucleosideAntimetabolite | Nucleoside Antimetabolite/Analog | Nucleoside Antimetabolite | neurons | nascent RNA | Inhibitor | inhibit | Analog | 5-EU | 5-Ethynyluridine | 5Ethynyluridine | 5 Ethynyluridine |
| Inhibitors Related | Stavudine | 5-Fluorouracil | Floxuridine | Adenosine | 8-Bromoguanosine | Uridine | Capecitabine | 5-BrdU | Vidarabine | Adenosine 5'-monophosphate disodium salt | Cytarabine | 6-Mercaptopurine |
| Related Compound Libraries | ReFRAME Related Library | Nucleotide Compound Library |
United States
